 |
|
Transplantation of Human Fetal Dopamine Cells for Parkinson's DiseaseResults at 1 Year
Curt R. Freed, MD;
Robert E. Breeze, MD;
Neil L. Rosenberg, MD;
Stuart A. Schneck, MD;
Trent H. Wells;
John N. Barrett, PhD;
Scott T. Grafton, MD;
S. C. Huang, DSc;
David Eidelberg, MD;
David A. Rottenberg, MD
Arch Neurol. 1990;47(5):505-512.
Abstract
| |
• In an effort to improve the clinical signs of Parkinson's disease, we have implanted mesencephalic dopamine cells from a 7-week human embryo into the caudate and putamen of a 52-year-old man with Parkinson's disease. Fetal tissue was obtained from elective abortion. The woman and the patient with Parkinson's disease were unknown to each other. The woman gave specific consent and was not paid. The patient had a 20-year history of parkinsonism treated with multiple drug therapies including levodopa/carbidopa (Sinemet) every 2 hours. His symptoms were worse on the left side. For 5 months prior to transplantation, the patient underwent clinical evaluations by both a neurologist and a computer system installed in his home for daily measurement of walking and hand movements. Preoperative positron emission tomographic scanning with 6-L[18F]fluorodopa (fluorodopa) demonstrated severe dopamine depletion bilaterally. Fetal tissue was matched to the patient for ABO blood antigens, and maternal serum was screened for hepatitis B and human immunodeficiency virus type 1 prior to surgery. Fetal tissue was implanted stereotactically throughout the caudate and putamen on the right side of the brain via 10 needle tracks. The patient was not immunosuppressed. Results 12 months after surgery showed 42% improvement in left-hand speed before the first morning dose of drug and 40% greater response to drug therapy. Righthand speed increased 15% before drug therapy and 23% after drug therapy. Reaction time was unaffected. Walking speed increased 33% after drug administration, although walking speed before the first morning dose of drugs declined 40%. Walking speed on an all-day basis improved 17%. "On" time increased from 69% to 86% of the day. For technical reasons, preoperative and postoperative fluorodopa positron emission tomographic scans were performed at different facilities, so that results could not be directly compared. A magnetic resonance scan 5 months after surgery showed that signs of the needle tracks were still visible but that there was no enhanced signal after gadolinium injection, indicating that the blood-brain barrier was intact. These data indicate that transplants of human fetal dopamine cells may have therapeutic benefit in patients with Parkinson's disease.
Author Affiliations
From the Departments of Medicine and Pharmacology (Dr Freed), Surgery (Dr Breeze), and Neurology (Drs Rosenberg and Schneck), University of Colorado Health Sciences Center, Denver; Trent Wells Inc, Los Angeles, Calif (Mr Wells); the Department of Physiology and Biophysics, University of Miami School of Medicine (Dr Barrett); the Departments of Neurology and Radiological Sciences (Drs Grafton and Huang), UCLA School of Medicine; and the Department of Neurology (Drs Eidelberg and Rottenberg), Sloan-Kettering Memorial Cancer Center, New York, NY.
Footnotes
Accepted for publication January 30, 1990.
Reprint requests to Department of Medicine, University of Colorado Health Sciences Center, 4200 E Ninth Ave, Denver, CO 80262 (Dr Freed).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Effects of Perceived Treatment on Quality of Life and Medical Outcomes in a Double-blind Placebo Surgery Trial
McRae et al.
Arch Gen Psychiatry 2004;61:412-420.
ABSTRACT
| FULL TEXT
Book Review: Cellular Replacement Therapy for Parkinson's Disease--Where We Are Today?
Redmond
Neuroscientist 2002;8:457-488.
ABSTRACT
Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?
Freed
Proc. Natl. Acad. Sci. USA 2002;99:1755-1757.
FULL TEXT
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed et al.
NEJM 2001;344:710-719.
ABSTRACT
| FULL TEXT
Long-term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease
Hauser et al.
Arch Neurol 1999;56:179-187.
ABSTRACT
| FULL TEXT
Understanding Parkinson Disease
Cummings
JAMA 1999;281:376-378.
FULL TEXT
Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells
Clarkson et al.
Proc. Natl. Acad. Sci. USA 1998;95:1265-1270.
ABSTRACT
| FULL TEXT
General Cognitive Ability Following Unilateral and Bilateral Fetal Ventral Mesencephalic Tissue Transplantation for Treatment of Parkinson's Disease
Sass et al.
Arch Neurol 1995;52:680-686.
ABSTRACT
Fetal Homotransplants in the Treatment of Parkinson's Disease-Reply
Madrazo and Franco-Bourland
Arch Neurol 1991;48:901-902.
ABSTRACT
Implantation of Human Fetal Ventral Mesencephalon to the Right Caudate Nucleus in Advanced Parkinson's Disease
Henderson et al.
Arch Neurol 1991;48:822-827.
ABSTRACT
Neurology
Joynt
JAMA 1991;265:3134-3135.
ABSTRACT
Comments on Brain Tissue Transplantation Without Immunosuppression
Freed and Poltorak
Arch Neurol 1991;48:259-260.
ABSTRACT
|
